RNA-Sequencing Based Assessment of Targets, Risk and Long Term Survival for Personalized Treatment of Multiple Myeloma

Martina Emde, Susanne Beck, Vladimir Benes, Jerome Moreaux, Anja Seckinger, Dirk Hose

Open source

DOI
10.1182/blood-2019-131159
Published
2019-11-13
Container
Blood
Publisher
American Society of Hematology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/blood-2019-131159,
  title = {RNA-Sequencing Based Assessment of Targets, Risk and Long Term Survival for Personalized Treatment of Multiple Myeloma},
  author = {Martina Emde and Susanne Beck and Vladimir Benes and Jerome Moreaux and Anja Seckinger and Dirk Hose},
  year = {2019},
  journal = {Blood},
  doi = {10.1182/blood-2019-131159},
  url = {https://doi.org/10.1182/blood-2019-131159}
}

RIS

TY  - JOUR
TI  - RNA-Sequencing Based Assessment of Targets, Risk and Long Term Survival for Personalized Treatment of Multiple Myeloma
AU  - Martina Emde
AU  - Susanne Beck
AU  - Vladimir Benes
AU  - Jerome Moreaux
AU  - Anja Seckinger
AU  - Dirk Hose
PY  - 2019
JO  - Blood
DO  - 10.1182/blood-2019-131159
UR  - https://doi.org/10.1182/blood-2019-131159
ER  - 

APA

Emde, M., Beck, S., Benes, V., Moreaux, J., Seckinger, A., & Hose, D. (2019). RNA-Sequencing Based Assessment of Targets, Risk and Long Term Survival for Personalized Treatment of Multiple Myeloma. Blood. https://doi.org/10.1182/blood-2019-131159

Source records